Home › Agent Hub › Agent Tools › Part D coverage by drug › Edarbyclor
Agent Tools
Edarbyclor is a brand of azilsartan / chlorthalidone. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 2,544 of 5,492 Medicare Part D and Medicare Advantage drug plans (46.3%) list Edarbyclor on their formulary, across 50 of 286 formularies. The most common placement is tier 4 (2,198 plans, 86.4% of those covering it). 0 of the covering plans require prior authorization (0%), 566 step therapy and 2,432 a quantity limit.
70 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $45, 21 of them $0; 2,474 charge coinsurance instead — median 25% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 2,807 of 5,496 plans covered it (51.1%); 2027: 2,544 of 5,492 (46.3%).
Of 4,367 plans offered in both years, 236 added it to the formulary and 297 dropped it.
Among plans covering it both years, 2 moved it to a higher tier and 202 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 5 |
| Tier 2 | 238 |
| Tier 3 | 103 |
| Tier 4 | 2,198 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 73 of 323 | 22.6% | 0% |
| Medicare Advantage with drugs (MA-PD) | 1,380 of 3,200 | 43.1% | 0% |
| Special needs plans (SNP) | 1,091 of 1,969 | 55.4% | 0% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 0 of 846 | No tier listed | 0 |
| UnitedHealthcare | 796 of 830 | Tier 4 | 0 |
| Devoted Health | 446 of 728 | Tier 4 | 0 |
| Aetna Medicare | 611 of 631 | Tier 4 | 0 |
| Wellcare | 234 of 268 | Tier 2 | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 0 of 83 | No tier listed | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 58 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 0 of 37 | No tier listed | 0 |
| Zing Health | 6 of 36 | Tier 4 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 29 of 29 | Tier 3 | 0 |
| Medica | 1 of 27 | Tier 3 | 0 |
| Anthem HealthKeepers | 22 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 0 of 26 | No tier listed | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 58 of 114 | 50.9% |
| Alaska | 2 of 9 | 22.2% |
| American Samoa | 1 of 1 | 100% |
| Arizona | 72 of 147 | 49% |
| Arkansas | 41 of 85 | 48.2% |
| California | 138 of 397 | 34.8% |
| Colorado | 52 of 106 | 49.1% |
| Connecticut | 36 of 54 | 66.7% |
| Delaware | 19 of 43 | 44.2% |
| District of Columbia | 7 of 12 | 58.3% |
| Florida | 236 of 545 | 43.3% |
| Georgia | 66 of 149 | 44.3% |
| Guam | 1 of 1 | 100% |
| Hawaii | 19 of 50 | 38% |
| Idaho | 18 of 45 | 40% |
| Illinois | 70 of 132 | 53% |
| Indiana | 77 of 138 | 55.8% |
| Iowa | 36 of 64 | 56.3% |
| Kansas | 47 of 84 | 56% |
| Kentucky | 64 of 121 | 52.9% |
| Louisiana | 73 of 125 | 58.4% |
| Maine | 32 of 52 | 61.5% |
| Maryland | 12 of 49 | 24.5% |
| Massachusetts | 22 of 89 | 24.7% |
| Michigan | 47 of 182 | 25.8% |
| Minnesota | 17 of 63 | 27% |
| Mississippi | 54 of 104 | 51.9% |
| Missouri | 103 of 170 | 60.6% |
| Montana | 4 of 27 | 14.8% |
| Nebraska | 26 of 51 | 51% |
| Nevada | 56 of 100 | 56% |
| New Hampshire | 10 of 25 | 40% |
| New Jersey | 36 of 73 | 49.3% |
| New Mexico | 36 of 68 | 52.9% |
| New York | 127 of 215 | 59.1% |
| North Carolina | 79 of 176 | 44.9% |
| North Dakota | 9 of 26 | 34.6% |
| Northern Mariana Islands | 1 of 1 | 100% |
| Ohio | 88 of 171 | 51.5% |
| Oklahoma | 33 of 81 | 40.7% |
| Oregon | 30 of 92 | 32.6% |
| Pennsylvania | 84 of 323 | 26% |
| Puerto Rico | 1 of 64 | 1.6% |
| Rhode Island | 14 of 29 | 48.3% |
| South Carolina | 38 of 89 | 42.7% |
| South Dakota | 11 of 30 | 36.7% |
| Tennessee | 68 of 156 | 43.6% |
| Texas | 236 of 407 | 58% |
| U.S. Virgin Islands | 1 of 1 | 100% |
| Utah | 29 of 53 | 54.7% |
| Vermont | 2 of 14 | 14.3% |
| Virginia | 69 of 144 | 47.9% |
| Washington | 54 of 114 | 47.4% |
| West Virginia | 30 of 69 | 43.5% |
| Wisconsin | 42 of 96 | 43.8% |
| Wyoming | 2 of 13 | 15.4% |
Medicare Part D paid for 111,116 30-day fills of Edarbyclor in 2024 for about 12,558 enrollees, at an average total cost of $235.48 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Edarbyclor and the rest of a client's list on every plan in their county.
Estimate Edarbyclor costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.